Vaccine‑preventable diseases are resurging globally, signaling a pivotal shift in infectious‑disease diagnostics.

Vaccine-preventable diseases are resurging — and the data is getting harder to ignore.

According to an article published by Discover Magazine (https://www.discovermagazine.com/measles-polio-and-other-vaccine-preventable-diseases-are-re-emerging-here-s-what-to-know-49467?utm_source=copilot.com), the U.S. has already recorded 2,300+ measles cases in 2026, surpassing last year’s total and marking a 35-year high. Globally, seven countries lost WHO measles elimination status between 2025–2026, reflecting a broader pattern of declining immunization rates and renewed transmission.

Experts point to several drivers: • Falling vaccination coverage post-COVID • Vaccine misinformation targeting MMR and other childhood vaccines • Policy disruptions that weaken evidence-based immunization guidance • Increasing importation and interstate spread, complicating elimination status reviews

For diagnostics manufacturers, hospital labs, and investors, this resurgence isn’t just a public health headline — it’s a market signal. Rising incidence of measles, polio, diphtheria, and other preventable diseases will reshape demand for molecular assays, serology platforms, point-of-care testing, and public health surveillance tools. Understanding where transmission is accelerating — and why — is now essential for strategic planning.

That’s exactly why we built the GRN IVD Consulting Infectious Disease Market Report: ✔️ Forecasts across vaccine-preventable diseases ✔️ Competitive landscapes for leading ID assay manufacturers ✔️ Policy-driven risk scenarios ✔️ Market implications of declining vaccination rates ✔️ Strategic recommendations for commercial, R&D, and medical affairs teams

If your organization needs to anticipate how shifting epidemiology will impact diagnostic demand, reimbursement, and competitive positioning, this report delivers the clarity you need. Contact us at grnivdconsulting@gmail.com to access the full report or explore a tailored briefing for your team.